Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGI
3876
Lazard Global Total Return & Income Fund
LGI
$240M
| $4.05M | ﹤0.01% |
276,658
+2,950
| +1% | +$42.7K |
|
|
BFZ
3877
DELISTED
BlackRock CA Municipal Income Trust
BFZ
| $4.05M | ﹤0.01% |
373,705
+3,552
| +1% | +$37.6K |
|
|
QUOT
3878
DELISTED
Quotient Technology Inc
QUOT
| $4.01M | ﹤0.01% |
1,169,849
+38,933
| +3% | +$110K |
|
3879
Enviri
NVRI
$625M
| $4.01M | ﹤0.01% |
637,656
-142,534
| -18% | -$849K |
|
|
OPNT
3880
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $4.01M | ﹤0.01% |
197,652
+190,441
| +2,641% | +$2.92M |
|
3881
Ardelyx
ARDX
$996M
| $4.01M | ﹤0.01% |
1,406,254
+714,798
| +103% | +$1.21M |
|
3882
iShares MSCI Thailand ETF
THD
$370M
| $4.01M | ﹤0.01% |
53,288
-2,829
| -5% | -$197K |
|
3883
iShares Asia 50 ETF
AIA
$4.73B
| $4.01M | ﹤0.01% |
70,615
+1,740
| +3% | +$92.4K |
|
3884
SLR Investment Corp
SLRC
$715M
| $4.01M | ﹤0.01% |
287,981
-43,527
| -13% | -$605K |
|
3885
Ooma
OOMA
$606M
| $4M | ﹤0.01% |
293,656
+13,288
| +5% | +$197K |
|
|
NTCO
3886
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $3.99M | ﹤0.01% |
921,372
+182,561
| +25% | +$884K |
|
|
TELL
3887
DELISTED
Tellurian Inc.
TELL
| $3.99M | ﹤0.01% |
2,372,321
-353,731
| -13% | -$886K |
|
3888
Codexis
CDXS
$160M
| $3.98M | ﹤0.01% |
854,171
+232,138
| +37% | +$1.27M |
|
3889
AC Immune
ACIU
$239M
| $3.98M | ﹤0.01% |
1,950,622
-26,730
| -1% | -$68.9K |
|
3890
Thryv Holdings
THRY
$108M
| $3.98M | ﹤0.01% |
209,248
-2,207
| -1% | -$43.1K |
|
3891
West Bancorporation
WTBA
$481M
| $3.97M | ﹤0.01% |
155,233
+104,866
| +208% | +$2.41M |
|
|
FFWM
3892
DELISTED
First Foundation Inc
FFWM
| $3.96M | ﹤0.01% |
276,052
+206,908
| +299% | +$3.2M |
|
3893
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
| $3.95M | ﹤0.01% |
77,966
+13,684
| +21% | +$679K |
|
3894
Biohaven
BHVN
$2.22B
| $3.95M | ﹤0.01% |
284,368
+267,026
| +1,540% | +$3.77M |
|
3895
Playtika
PLTK
$1.12B
| $3.94M | ﹤0.01% |
463,464
-85,226
| -16% | -$790K |
|
3896
Manitowoc
MTW
$677M
| $3.94M | ﹤0.01% |
430,218
-1,185
| -0.3% | -$10.8K |
|
|
VNET
3897
VNET Group
VNET
$2.09B
| $3.92M | ﹤0.01% |
690,707
-351,557
| -34% | -$1.81M |
|
|
VTYX
3898
DELISTED
Ventyx Biosciences
VTYX
| $3.91M | ﹤0.01% |
119,214
+36,449
| +44% | +$1.08M |
|
3899
Arrow Financial
AROW
$657M
| $3.91M | ﹤0.01% |
118,701
+46,318
| +64% | +$1.5M |
|
3900
Aspen Aerogels
ASPN
$515M
| $3.9M | ﹤0.01% |
330,867
-95,056
| -22% | -$1.09M |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.